Plant-derived (non-animal derived, NAD) D-Galactose

 

Published date: Aug 26, 2018   Tags: plant derived D-galactose 59-23-4 D-Galactopyranose NAD plant origin plant source galactose D-(+)-Galactose China GMP manufacturer

What is D-Galactose

D-Galactose is an aldohexose that occurs naturally in the body, It is commonly found in dairy products, sugar beets, certain gums and mucilages. 


D-Galacose is a basic ingredient usually used for creating brain senescence in animal models, increasing glycoproteins production through adding to cell culture medium.  As one of primary monosaccharides, D-Galactose can be acted as a basic start material for synthesis of many important intermediates. Certain medications contain galactose as excipient.


Plant derived, low endotoxin D-galactose is specifically for biopharmaceutical use, It can serve as a key, chemically defined component to optimize protein production while reducing lactate and ammonia formation. 

 

Properties

CAS No: 59-23-4
EINECS: 200-416-4
Alias Name: Glactose;  D-Galactopyranose; α-D-Galactopyranose; alpha-D-Galactopyranose;D-(+)-Galactose
Chemical Structure:
Molecular Formula: C6H12O6
Molecular Weight: 180.16
Assay: NLT 98.5% / 99.0%
Solubility: Easily soluble in water
Specific Rotation: +78.0º to +81.5º
Application:

Targeted drug development
Biochemical reagent
Ingredient for cell culture medium
Start material for synthesis
Excipient

 

Applicaion

Ingredient for Cell Culture Medium

The terminal sialic acid component of a glycoprotein oligosaccharide side chain is known to have an effect on numerous aspects and properties of a glycoprotein, including absorption, solubility, thermal stability, serum half life, clearance from the serum, as well as its physical and chemical structure/behavior and its immunogenicity.

The sialic content of the produced glycoproteins is increased and enhanced when D-galactose is added to feed medium. If D-galactose is supplied daily to the cells during the entire culture period,  it will increasing the quality of the final glycoprotein product. 

Developing  Targeted Drugs

Asialoglycoprotein receptor (ASGPR) was specifically expressed by hepatocytes, which could recognize and bind asialoglycoprotein, galactose (Gal), galactosamine, N-acetylgalactosamine (GalNAc), etc. with high affinity. 

Targeted delivery of modified lipoprotein particles, genes, chemically modified oligonucleotides, nucleoside analogue (eg. Ribavirin), small molecule compounds(eg. Doxorubicin), siRNA, and microRNA antagonists to hepatocytes through this mechanism are under developing.

Start material for synthesis

D-Galctose is a basic bone acting as the start material for many kinds of pharmaceutical and biochemical intermediate, such as Diacetone-D-galactose (1,2:3,4-Di-O-Isopropylidene-α-D-Galactopyranose) , beta-D-Galactose pentaacetate, methyl-D-galactopyranoside.

 

Yixin's advantages

Plant-derived, NAD

Yixin’s plant derived D-galactose (NAD) is  completely from nature tree, non GMO source, developed specifically for biopharmaceutical  use. 

  

GMO High Risk Crops & Inputs

-Crops

Alfalfa, Canola, Corn (except popcorn), Cotton, Papaya, Soy, Sugar beet, Zucchini/Yellow summer squash, Canola

-Animal Derivatives

Meat, Eggs, Milk, Products of Apiculture (e.g., Honey), Products of Aquaculture (e.g., Fish), Gelatin, Hides and Skin

-Microbes and Microbial Products

Enzymes (e.g., chymosin), Cultures and starters including yeast, Algae from aquaculture

 

Refer to https://www.nongmoproject.org/gmo-facts/high-risk/

Low Endotoxin

Yixin plant derived D-galactose controls Endotoxin at the very low level to ensure the highest quality  in biopharmaceutical products. It can meet special requirement less than 5 EU/g or more stricter requirement.

GMP  system

Yixin plant derived D-galactose is produced under GMP system to ensure the traceability and consistent supply. Yixin GMP system was  established and improved over  20 years,  for carbohydrates facility,  NSF GMP certificate has been obtained since 2015, In 2015 Yixin carbohydrate facility was inspected  and concluded by US FDA to meet the related requirements.

-In 2015-2018 Yixin Carbohydrates facility was assessed by NSF international and found to be in compliance with GMP Requirements in NSF/ANSI Standard173,Section B Dietary Supplements.

-Yixin Carbohydrates Facility was inspected in 2015 by US.FDA, it’s concluded to meet the related requirement of Dietary Supplement Ingredient.

-In 2015-2018 Yixin Carbohydrates facility were certificated by 3rd Kosher certification organization.

-Since 2002, Yixin has obtained the Certificates of GMP from CFDA for 9 dosage forms successively including capsules, tablets, syrup, preparation for external use and  etc. In 2006 and 2011 Yixin facility of API was inspected and classified as acceptable by US FDA.

Contact Us

Our Contact Information

Zhejiang Yixin Pharmaceutical Co., Ltd.
East Round Road, Lanxi
Zhejiang, 321100, China
Tel:+86-579-88865135, 5136
Fax:+86-579-88865169
Email: sale@herbs-tech.com
Skype: shaobinbao , hj.howdor

©2017-2018 Zhejiang Yixin Pharmaceutical Co., Ltd.  

About us | Privacy Policy | Brochure

EN |  CN  |  DE  |  FR  |  JA  |  RU